Lack of illness insight Many individuals with schizophrenia have poor or no insight into their illness, meaning that they are not aware of the symptoms and consequences of their illness. Four studies (two prospective studies [Acosta et al. 2009; Loffler et al. 2003], one cross-sectional study [Olfson et al. 2006] and the survey of experts [Velligan et al. 2009]) found a directional Inhibitors,research,lifescience,medical relation in which lack of illness insight was associated with worse adherence. In fact, the survey involving clinical experts [Velligan et al. 2009] rated poor illness insight as the most important factor contributing to nonadherence. Another cross-sectional study [Aldebot and de Mamani, 2009] reported that individuals who

dealt with the stress of their illness by ignoring their illness or the magnitude of their symptoms were less Inhibitors,research,lifescience,medical adherent to their medication. The author hypothesized that patients who refused to accept being ill may not believe that their symptoms

are something that can be managed, and thus, may be less motivated to take steps to resolve their symptoms, such as taking medication. Only one prospective study [Linden et al. 2001] reported Inhibitors,research,lifescience,medical no relation between adherence and lack of insight. The author states that this contrary finding may be due to the inclusion of more adherent patients which may, in turn, influence the overall findings concerning patient adherence. Patient-related than factors Six types of patient-related factors were reviewed: sociodemographic factors, substance abuse, Inhibitors,research,lifescience,medical beliefs about medication, prior adherence, obesity and religious factors. Sociodemographic factors Four studies (three prospective studies [Acosta et al. 2009; Linden et al. 2001; Loffler et al. 2003] and one cross-sectional study [Aldebot and de Mamani, 2009]) did not show a relation

between adherence and sociodemographic variables such as gender [Acosta et al. 2009; Aldebot and de Mamani, 2009; Linden et al. 2001], age [Acosta et al. 2009], family/marital status [Acosta et al. 2009; Linden Inhibitors,research,lifescience,medical et al. 2001], ethnicity [Aldebot and de Mamani, 2009], occupational status/qualification [Linden et al. 2001] and level of education [Acosta et al. 2009; Aldebot and de Mamani, 2009; Linden et al. 2001; Loffler et al. 2003]. However, three prospective studies [Hudson et al. 2004; Janssen et al. 2006; Linden et al. 2001] and one Carfilzomib retrospective database study [Valenstein et al. 2004] did report a positive relationship between sociodemographic factors and adherence. For example, a positive relationship with older age [Linden et al. 2001; Valenstein et al. 2004], and a negative relationship with low education level [Hudson et al. 2004; Janssen et al. 2006] were scientific study identified. In addition, one study found that African Americans were more likely to have poor adherence compared with white people [Valenstein et al. 2004]. Substance use Five studies (four prospective studies [Ascher-Svanum, 2006; Hudson et al. 2004; Janssen et al. 2006; Novick et al.